Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

EUS-guided pancreatic fluid aspiration for DNA analysis of KRAS and GNAS mutations for the evaluation of pancreatic cystic neoplasia: a pilot study.

Siddiqui AA, Kowalski TE, Kedika R, Roy A, Loren DE, Ellsworth E, Adler D, Finkelstein SD.

Gastrointest Endosc. 2013 Apr;77(4):669-70. doi: 10.1016/j.gie.2012.11.009. No abstract available.

PMID:
23498145
[PubMed - indexed for MEDLINE]
2.

Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, Goggins M, Canto MI, Schulick RD, Edil BH, Wolfgang CL, Klein AP, Diaz LA Jr, Allen PJ, Schmidt CM, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein B.

Sci Transl Med. 2011 Jul 20;3(92):92ra66. doi: 10.1126/scitranslmed.3002543.

PMID:
21775669
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.

Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, Chennat JS, Slivka A, Zeh HJ, Zureikat AH, Krasinskas AM, Ohori NP, Schoedel KE, Navina S, Mantha GS, Pai RK, Singhi AD.

Mod Pathol. 2013 Nov;26(11):1478-87. doi: 10.1038/modpathol.2013.91. Epub 2013 Jun 7.

PMID:
23743931
[PubMed - indexed for MEDLINE]
4.

BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.

Hosoda W, Sasaki E, Murakami Y, Yamao K, Shimizu Y, Yatabe Y.

Pathol Int. 2013 Mar;63(3):176-82. doi: 10.1111/pin.12045.

PMID:
23530562
[PubMed - indexed for MEDLINE]
5.

Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.

Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, Hruban RH, Maitra A, Kinzler K, Vogelstein B, Goggins M.

Gastroenterology. 2012 Apr;142(4):730-733.e9. doi: 10.1053/j.gastro.2011.12.042. Epub 2012 Jan 5.

PMID:
22226782
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".

Matthaei H, Wu J, Dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Kalff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RH.

Am J Surg Pathol. 2014 Mar;38(3):360-3. doi: 10.1097/PAS.0000000000000117.

PMID:
24525507
[PubMed - indexed for MEDLINE]
7.

Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts.

Kanda M, Knight S, Topazian M, Syngal S, Farrell J, Lee J, Kamel I, Lennon AM, Borges M, Young A, Fujiwara S, Seike J, Eshleman J, Hruban RH, Canto MI, Goggins M.

Gut. 2013 Jul;62(7):1024-33. doi: 10.1136/gutjnl-2012-302823. Epub 2012 Aug 2.

PMID:
22859495
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Association between KRAS mutation, detected in pancreatic cyst fluid, and long-term outcomes of patients.

Rockacy MJ, Zahid M, McGrath KM, Fasanella KE, Khalid A.

Clin Gastroenterol Hepatol. 2013 Apr;11(4):425-9. doi: 10.1016/j.cgh.2012.12.008. Epub 2012 Dec 23.

PMID:
23267865
[PubMed - indexed for MEDLINE]
9.

Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.

Khalid A, Zahid M, Finkelstein SD, LeBlanc JK, Kaushik N, Ahmad N, Brugge WR, Edmundowicz SA, Hawes RH, McGrath KM.

Gastrointest Endosc. 2009 May;69(6):1095-102. doi: 10.1016/j.gie.2008.07.033. Epub 2009 Jan 18.

PMID:
19152896
[PubMed - indexed for MEDLINE]
10.

Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis.

Wang X, Gao J, Ren Y, Gu J, Du Y, Chen J, Jin Z, Zhan X, Li Z, Huang H, Lv S, Gong Y.

Am J Gastroenterol. 2011 Dec;106(12):2104-11. doi: 10.1038/ajg.2011.281. Epub 2011 Aug 30.

PMID:
21876563
[PubMed - indexed for MEDLINE]
11.

Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis.

Bournet B, Souque A, Senesse P, Assenat E, Barthet M, Lesavre N, Aubert A, O'Toole D, Hammel P, Levy P, Ruszniewski P, Bouisson M, Escourrou J, Cordelier P, Buscail L.

Endoscopy. 2009 Jun;41(6):552-7. doi: 10.1055/s-0029-1214717. Epub 2009 Jun 16.

PMID:
19533561
[PubMed - indexed for MEDLINE]
12.

Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, Ito T, Ishigami K, Tokunaga S, Ohuchida K, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Ann Surg. 2013 Jul;258(1):141-51. doi: 10.1097/SLA.0b013e31828cd008.

PMID:
23532108
[PubMed - indexed for MEDLINE]
13.

A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.

Sreenarasimhaiah J, Lara LF, Jazrawi SF, Barnett CC, Tang SJ.

JOP. 2009 Mar 9;10(2):163-8.

PMID:
19287110
[PubMed - indexed for MEDLINE]
Free Article
14.

Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.

Reicher S, Boyar FZ, Albitar M, Sulcova V, Agersborg S, Nga V, Zhou Y, Li G, Venegas R, French SW, Chung DS, Stabile BE, Eysselein VE, Anguiano A.

Pancreas. 2011 Oct;40(7):1057-62. doi: 10.1097/MPA.0b013e3182200201.

PMID:
21705950
[PubMed - indexed for MEDLINE]
15.

Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.

Sawhney MS, Devarajan S, O'Farrel P, Cury MS, Kundu R, Vollmer CM, Brown A, Chuttani R, Pleskow DK.

Gastrointest Endosc. 2009 May;69(6):1106-10. doi: 10.1016/j.gie.2008.08.015. Epub 2009 Feb 26.

PMID:
19249035
[PubMed - indexed for MEDLINE]
16.

Optimizing the multimodal approach to pancreatic cyst fluid diagnosis: developing a volume-based triage protocol.

Chai SM, Herba K, Kumarasinghe MP, de Boer WB, Amanuel B, Grieu-Iacopetta F, Lim EM, Segarajasingam D, Yusoff I, Choo C, Frost F.

Cancer Cytopathol. 2013 Feb;121(2):86-100. doi: 10.1002/cncy.21226. Epub 2012 Sep 7.

PMID:
22961878
[PubMed - indexed for MEDLINE]
17.

Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.

Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, Tsuda H, Kanai Y.

J Pathol. 2013 Mar;229(4):579-87. doi: 10.1002/path.4153. Epub 2013 Feb 4.

PMID:
23208952
[PubMed - indexed for MEDLINE]
18.

Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.

Maluf-Filho F, Kumar A, Gerhardt R, Kubrusly M, Sakai P, Hondo F, Matuguma SE, Artifon E, Monteiro da Cunha JE, C├ęsar Machado MC, Ishioka S, Forero E.

J Clin Gastroenterol. 2007 Nov-Dec;41(10):906-10.

PMID:
18090159
[PubMed - indexed for MEDLINE]
19.

K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.

Schoedel KE, Finkelstein SD, Ohori NP.

Diagn Cytopathol. 2006 Sep;34(9):605-8.

PMID:
16900481
[PubMed - indexed for MEDLINE]
20.

Intraductal tubulopapillary neoplasm of the pancreas on fine needle aspiration: case report with differential diagnosis.

Guan H, Gurda G, Lennon AM, Hruban RH, Erozan YS.

Diagn Cytopathol. 2014 Feb;42(2):156-60. doi: 10.1002/dc.22890. Epub 2012 Jul 16.

PMID:
22807417
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk